Do statins delay the incidence of ESRD in diabetic patients with moderate CKD?
Conley
James
J
Nephrology Section, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin 53793, USA.
Olafsson
Andrew
A
Djamali
Arjang
A
D000328:Adult; D008078:Cholesterol, LDL / Q000097:blood; D002908:Chronic Disease; D048909:Diabetes Complications / Q000188:drug therapy*; D018450:Disease Progression; D005260:Female; D005919:Glomerular Filtration Rate; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D015994:Incidence; D007674:Kidney Diseases / Q000188:drug therapy*; D007676:Kidney Failure, Chronic / Q000453:epidemiology / Q000517:prevention & control*; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies
D008078:Cholesterol, LDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors